
Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study.
- Author
- L ALLEGRA, N KONIETZKO, P LEOPHONTE, J HOSIE, Romain Pauwels, JN GUYEN and P PETITPRETZ
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-188255
- Chicago
- ALLEGRA, L, N KONIETZKO, P LEOPHONTE, J HOSIE, Romain Pauwels, JN GUYEN, and P PETITPRETZ. 1996. “Safety and Efficacy of Sparfloxacin in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Double-blind, Randomised, Parallel, Multicentre Study.” Journal of Antimicrobial Chemotherapy (93-104 Suppl. A).
- APA
- ALLEGRA, L., KONIETZKO, N., LEOPHONTE, P., HOSIE, J., Pauwels, R., GUYEN, J., & PETITPRETZ, P. (1996). Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (93-104 Suppl. A).
- Vancouver
- 1.ALLEGRA L, KONIETZKO N, LEOPHONTE P, HOSIE J, Pauwels R, GUYEN J, et al. Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1996;(93-104 Suppl. A).
- MLA
- ALLEGRA, L, N KONIETZKO, P LEOPHONTE, et al. “Safety and Efficacy of Sparfloxacin in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Double-blind, Randomised, Parallel, Multicentre Study.” JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 93-104 Suppl. A (1996): n. pag. Print.
@article{188255, author = {ALLEGRA, L and KONIETZKO, N and LEOPHONTE, P and HOSIE, J and Pauwels, Romain and GUYEN, JN and PETITPRETZ, P}, issn = {0305-7453}, journal = {JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY}, language = {eng}, number = {93-104 Suppl. A}, title = {Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study.}, year = {1996}, }